Literature DB >> 19884614

Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.

Eric van Exel1, Piet Eikelenboom, Hannie Comijs, Marijke Frölich, Johannes H Smit, Max L Stek, Philip Scheltens, Jan E Eefsting, Rudi G J Westendorp.   

Abstract

CONTEXT: Alzheimer disease (AD) is a complex disorder with a strong heritable component. Amyloid pathology, vascular factors, and inflammation are postulated to be involved in its pathogenesis, but causality has not been established unequivocally.
OBJECTIVE: To identify heritable traits in middle age that contribute to AD.
DESIGN: We used a proven family design, comparing middle-aged offspring with and without a parental history of AD. In such a design, the offspring under study are enriched for risk factors of AD but do not yet have the disease.
SETTING: The Netherlands. PARTICIPANTS: Two hundred six offspring of 92 families with a parental history of late-onset AD and 200 offspring of 97 families without a parental history of AD. MAIN OUTCOME MEASURES: The APOE epsilon4 genotype, vascular factors, production capacity of pro- and anti-inflammatory cytokines upon stimulation with lipopolysaccharide, and circulating markers of inflammation. All outcome measures were assessed in the offspring only and not in the parental generation.
RESULTS: More offspring with a parental history of AD carried APOE epsilon4 than those without a parental history of the disease (47% vs 21%, P < .001). Those with a parental history of AD also had higher systolic blood pressures (P = .006), higher diastolic blood pressures (P < .001), and lower ankle brachial indices (P = .005) when compared with offspring without a family history of dementia. Production capacity of pro-inflammatory cytokines in offspring with a parental history of AD was also different, with higher levels of IL-1beta (interleukin 1beta) (P < .001), IL-1beta to IL-1ra ratio (P < .001), tumor necrosis factor alpha (P = .008), IL-6 (P = .04), and interferon gamma (P = .01). All of these positive associations were independent of APOE epsilon4 genotype.
CONCLUSIONS: Hypertension and the expression of an innate pro-inflammatory cytokine profile in middle age are early risk factors of AD in old age. For the offspring of affected families, it provides clues for screening and preventive strategies, of which blood pressure control can be implemented directly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19884614     DOI: 10.1001/archgenpsychiatry.2009.146

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  36 in total

1.  Men Have a Stronger Monocyte-Derived Cytokine Production Response upon Stimulation with the Gram-Negative Stimulus Lipopolysaccharide than Women: A Pooled Analysis Including 15 Study Populations.

Authors:  Karel G M Beenakker; Rudi G J Westendorp; Anton J M de Craen; Sijia Chen; Yotam Raz; Bart E P B Ballieux; Rob G H H Nelissen; Alexander F L Later; Tom W Huizinga; Pieternella E Slagboom; Dorret I Boomsma; Andrea B Maier
Journal:  J Innate Immun       Date:  2019-06-21       Impact factor: 7.349

2.  Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease.

Authors:  Ozioma C Okonkwo; Guofan Xu; Jennifer M Oh; N Maritza Dowling; Cynthia M Carlsson; Catherine L Gallagher; Alex C Birdsill; Matthew Palotti; Whitney Wharton; Bruce P Hermann; Asenath LaRue; Barbara B Bendlin; Howard A Rowley; Sanjay Asthana; Mark A Sager; Sterling C Johnson
Journal:  Cereb Cortex       Date:  2012-12-12       Impact factor: 5.357

Review 3.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

4.  Biomarkers of Alzheimer's disease among Mexican Americans.

Authors:  Sid E O'Bryant; Guanghua Xiao; Melissa Edwards; Michael Devous; Veer Bala Gupta; Ralph Martins; Fan Zhang; Robert Barber
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

Authors:  Douglas Galasko; Thomas J Montine
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

6.  Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.

Authors:  Sema Uslu; Zubeyde Eken Akarkarasu; Demet Ozbabalik; Serhat Ozkan; Omer Colak; Emine Sutken Demirkan; Ayşe Ozkiris; Canan Demirustu; Ozkan Alatas
Journal:  Neurochem Res       Date:  2012-03-22       Impact factor: 3.996

7.  Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.

Authors:  Robyn A Honea; Russell H Swerdlow; Eric D Vidoni; Jeffrey M Burns
Journal:  Neurology       Date:  2011-03-01       Impact factor: 9.910

8.  Pinpointing key mechanisms in Alzheimer's disease development.

Authors:  Julie Williams
Journal:  Alzheimers Res Ther       Date:  2010-03-31       Impact factor: 6.982

9.  Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?

Authors:  Zaldy S Tan; Sudha Seshadri
Journal:  Alzheimers Res Ther       Date:  2010-04-12       Impact factor: 6.982

10.  How predictive of dementia are peripheral inflammatory markers in the elderly?

Authors:  Andrea L Metti; Jane A Cauley
Journal:  Neurodegener Dis Manag       Date:  2012-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.